Endo Can't Stop Settlement Order In Frova Patent Row
The Federal Circuit on Thursday refused to halt an order requiring Endo Pharmaceuticals Inc. and Mylan Pharmaceuticals Inc. to negotiate a settlement in their infringement row over Endo's patent for migraine...To view the full article, register now.
Already a subscriber? Click here to view full article